ENLV - Company ID 0001596812
Enlivex Therapeutics Ltd. has filed 393 public company documents between 2014 and 2026. The most frequent type is 6-k (267 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Type | Filing | Filed | Period covered | Open |
|---|---|---|---|---|
| 6-K | 6-K | 1mo ago2026-05-28 | 2026-05-28 | View filing |
| 6-K | 6-K | 1mo ago2026-05-27 | 2026-05-27 | View filing |
| 6-K | 6-K | 1mo ago2026-05-18 | 2026-05-18 | View filing |
| 6-K | 6-K | 1mo ago2026-05-15 | 2026-05-15 | View filing |
| 424B3 | 424B3 | 2mo ago2026-05-01 | - | View filing |
| EFFECT | EFFECT | 2mo ago2026-04-30 | - | View filing |
| F-3 | F-3 | 2mo ago2026-04-21 | - | View filing |
| 6-K | 6-K | 2mo ago2026-04-21 | 2026-04-21 | View filing |
| 6-K | 6-K | 3mo ago2026-04-08 | 2026-04-08 | View filing |
| 6-K | 6-K | 3mo ago2026-03-26 | 2026-03-26 | View filing |
| 20-F | 20-F | 3mo ago2026-03-25 | 2025-12-31 | View filing |
| 6-K | 6-K | 3mo ago2026-03-25 | 2026-03-25 | View filing |
| 6-K | 6-K | 3mo ago2026-03-24 | 2026-03-24 | View filing |
| 6-K | 6-K | 3mo ago2026-03-23 | 2026-03-23 | View filing |
| 424B3 | 424B3 | 3mo ago2026-03-20 | - | View filing |
| 3 | New insider ownership | 3mo ago2026-03-18 | 2026-03-18 | View filing |
| 3 | New insider ownership | 3mo ago2026-03-18 | 2026-03-18 | View filing |
| 3 | New insider ownership | 3mo ago2026-03-18 | 2026-03-18 | View filing |
| 3 | New insider ownership | 3mo ago2026-03-18 | 2026-03-18 | View filing |
| 3 | New insider ownership | 3mo ago2026-03-18 | 2026-03-18 | View filing |
| 3 | New insider ownership | 3mo ago2026-03-18 | 2026-03-18 | View filing |
| 3 | New insider ownership | 3mo ago2026-03-18 | 2026-03-18 | View filing |
| S-8 | Employee stock plan | 4mo ago2026-03-13 | - | View filing |
| 6-K | 6-K | 4mo ago2026-02-23 | 2026-02-23 | View filing |
| 6-K | 6-K | 5mo ago2026-02-10 | 2026-02-10 | View filing |
| 6-K | 6-K | 5mo ago2026-02-05 | 2026-02-05 | View filing |
| 6-K | 6-K | 5mo ago2026-01-26 | 2026-01-26 | View filing |
| 6-K | 6-K | 5mo ago2026-01-23 | 2026-01-23 | View filing |
| 6-K | 6-K | 6mo ago2026-01-07 | 2026-01-07 | View filing |
| 424B3 | 424B3 | 6mo ago2026-01-06 | - | View filing |
| EFFECT | EFFECT | 6mo ago2026-01-02 | - | View filing |
| CORRESP | Company correspondence | 6mo ago2025-12-30 | - | View filing |
| UPLOAD | SEC correspondence | 6mo ago2025-12-29 | - | View filing |
| F-3 | F-3 | 6mo ago2025-12-23 | - | View filing |
| 6-K | 6-K | 6mo ago2025-12-18 | 2025-12-18 | View filing |
| 6-K | 6-K | 7mo ago2025-12-04 | 2025-12-04 | View filing |
| 6-K | 6-K | 7mo ago2025-11-26 | 2025-11-26 | View filing |
| 6-K | 6-K | 7mo ago2025-11-24 | 2025-11-24 | View filing |
| 424B5 | Prospectus supplement | 7mo ago2025-11-24 | - | View filing |
| 6-K | 6-K | 7mo ago2025-11-24 | 2025-11-24 | View filing |
| 6-K | 6-K | 7mo ago2025-11-18 | 2025-11-18 | View filing |
| 6-K | 6-K | 8mo ago2025-11-14 | 2025-11-14 | View filing |
| 6-K | 6-K | 8mo ago2025-11-10 | 2025-11-10 | View filing |
| 6-K | 6-K | 9mo ago2025-09-25 | 2025-09-25 | View filing |
| 6-K | 6-K | 10mo ago2025-09-11 | 2025-09-11 | View filing |
| 6-K | 6-K | 10mo ago2025-09-09 | 2025-09-09 | View filing |
| 6-K | 6-K | 10mo ago2025-08-29 | 2025-06-30 | View filing |
| 6-K | 6-K | 10mo ago2025-08-18 | 2025-08-18 | View filing |
| 6-K | 6-K | 10mo ago2025-08-18 | 2025-08-18 | View filing |
| 6-K | 6-K | 11mo ago2025-08-14 | 2025-08-14 | View filing |